Cargando…

BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa

INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Berendsen, Mike LT, van Gijzel, Sjors WL, Smits, Jeroen, de Mast, Quirijn, Aaby, Peter, Benn, Christine S, Netea, Mihai G, van der Ven, Andre JAM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861070/
https://www.ncbi.nlm.nih.gov/pubmed/31798997
http://dx.doi.org/10.1136/bmjgh-2019-001862
_version_ 1783471277338525696
author Berendsen, Mike LT
van Gijzel, Sjors WL
Smits, Jeroen
de Mast, Quirijn
Aaby, Peter
Benn, Christine S
Netea, Mihai G
van der Ven, Andre JAM
author_facet Berendsen, Mike LT
van Gijzel, Sjors WL
Smits, Jeroen
de Mast, Quirijn
Aaby, Peter
Benn, Christine S
Netea, Mihai G
van der Ven, Andre JAM
author_sort Berendsen, Mike LT
collection PubMed
description INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores whether BCG is associated with protection against malaria in children under the age of 5 years in SSA. METHODS: We used data from the Demographic Health Survey programme, including 34 206 children from 13 SSA countries. BCG status was taken from vaccination cards when present; if not, mother’s recall was used. Presence of malaria was defined as a positive rapid diagnostic test. Maternally reported presence or absence of fever in the previous 2 weeks defined symptomatic status. Multilevel logistic regression was used to account for the two-stage cluster sampling method. RESULTS: Of the 34 206 children, 12 325 (36.0%) children were malaria positive and 29 766 (87.0%) were BCG vaccinated. After correction for relevant child, maternal and household factors, BCG vaccination was associated with a lower malaria prevalence (adjusted OR (aOR)=0.94, 95% CI 0.90 to 0.98), especially among children of whom BCG information was retrieved from a vaccination card (aOR(card)=0.88, 95% CI 0.82 to 0.94). Restricting the analysis to children from regions with suboptimal BCG coverage increased the association (aOR(card)=0.81, 95% CI 0.73 to 0.89). We observed an increasingly beneficial association with each month of age of the child (aOR(card)=0.996, 95% CI 0.993 to 0.999). BCG associations were similar for asymptomatic (aOR(card)=0.86, 95% CI 0.81 to 0.92) and symptomatic (aOR(card)=0.89, 95% CI 0.78 to 1.01) malaria. CONCLUSIONS: BCG vaccination is associated with protection against malaria. This protection is highest in regions with suboptimal BCG coverage. These results indicate a possible role for timely BCG vaccination in the protection of malaria and its elimination by reducing the transmission reservoir. If confirmed in further research, our findings have substantial implications for global efforts to reduce malaria burden.
format Online
Article
Text
id pubmed-6861070
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-68610702019-12-03 BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa Berendsen, Mike LT van Gijzel, Sjors WL Smits, Jeroen de Mast, Quirijn Aaby, Peter Benn, Christine S Netea, Mihai G van der Ven, Andre JAM BMJ Glob Health Research INTRODUCTION: Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores whether BCG is associated with protection against malaria in children under the age of 5 years in SSA. METHODS: We used data from the Demographic Health Survey programme, including 34 206 children from 13 SSA countries. BCG status was taken from vaccination cards when present; if not, mother’s recall was used. Presence of malaria was defined as a positive rapid diagnostic test. Maternally reported presence or absence of fever in the previous 2 weeks defined symptomatic status. Multilevel logistic regression was used to account for the two-stage cluster sampling method. RESULTS: Of the 34 206 children, 12 325 (36.0%) children were malaria positive and 29 766 (87.0%) were BCG vaccinated. After correction for relevant child, maternal and household factors, BCG vaccination was associated with a lower malaria prevalence (adjusted OR (aOR)=0.94, 95% CI 0.90 to 0.98), especially among children of whom BCG information was retrieved from a vaccination card (aOR(card)=0.88, 95% CI 0.82 to 0.94). Restricting the analysis to children from regions with suboptimal BCG coverage increased the association (aOR(card)=0.81, 95% CI 0.73 to 0.89). We observed an increasingly beneficial association with each month of age of the child (aOR(card)=0.996, 95% CI 0.993 to 0.999). BCG associations were similar for asymptomatic (aOR(card)=0.86, 95% CI 0.81 to 0.92) and symptomatic (aOR(card)=0.89, 95% CI 0.78 to 1.01) malaria. CONCLUSIONS: BCG vaccination is associated with protection against malaria. This protection is highest in regions with suboptimal BCG coverage. These results indicate a possible role for timely BCG vaccination in the protection of malaria and its elimination by reducing the transmission reservoir. If confirmed in further research, our findings have substantial implications for global efforts to reduce malaria burden. BMJ Publishing Group 2019-11-14 /pmc/articles/PMC6861070/ /pubmed/31798997 http://dx.doi.org/10.1136/bmjgh-2019-001862 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Berendsen, Mike LT
van Gijzel, Sjors WL
Smits, Jeroen
de Mast, Quirijn
Aaby, Peter
Benn, Christine S
Netea, Mihai G
van der Ven, Andre JAM
BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title_full BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title_fullStr BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title_full_unstemmed BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title_short BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
title_sort bcg vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-saharan africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861070/
https://www.ncbi.nlm.nih.gov/pubmed/31798997
http://dx.doi.org/10.1136/bmjgh-2019-001862
work_keys_str_mv AT berendsenmikelt bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT vangijzelsjorswl bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT smitsjeroen bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT demastquirijn bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT aabypeter bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT bennchristines bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT neteamihaig bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica
AT vandervenandrejam bcgvaccinationisassociatedwithreducedmalariaprevalenceinchildrenundertheageof5yearsinsubsaharanafrica